Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million
HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Tuesday reported net income of $622,000 in its first quarter. On a per-share basis, the Holliston, Massachusetts-based company said it had profit of 1 cent.
25.04.2023 - Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million prior year HOLLISTON, Mass., April 25, 2023 ...
Harvard Bioscience (NASDAQ:HBIO – Get Rating) is set to announce its earnings results before the market opens on Tuesday, April 25th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. Harvard Bioscience Stock Up […]
Monarch Partners Asset Management LLC reduced its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) by 23.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 613,837 shares of the medical instruments supplier’s stock after selling 187,422 shares during the quarter. Monarch Partners Asset […]